Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143


Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.

Bossow S, Grossardt C, Temme A, Leber MF, Sawall S, Rieber EP, Cattaneo R, von Kalle C, Ungerechts G.

Cancer Gene Ther. 2011 Aug;18(8):598-608. doi: 10.1038/cgt.2011.30. Epub 2011 Jun 24.


Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia.

Bornhäuser M, Thiede C, Platzbecker U, Kiani A, Oelschlaegel U, Babatz J, Lehmann D, Hölig K, Radke J, Tuve S, Wermke M, Wehner R, Jähnisch H, Bachmann MP, Rieber EP, Schetelig J, Ehninger G, Schmitz M.

Blood. 2011 Jun 30;117(26):7174-84. doi: 10.1182/blood-2010-09-308569. Epub 2011 May 3.


The prostate stem cell antigen represents a novel glioma-associated antigen.

Geiger KD, Hendruschk S, Rieber EP, Morgenroth A, Weigle B, Juratli T, Senner V, Schackert G, Temme A.

Oncol Rep. 2011 Jul;26(1):13-21. doi: 10.3892/or.2011.1265. Epub 2011 Apr 15.


Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cells.

Stamova S, Cartellieri M, Feldmann A, Bippes CC, Bartsch H, Wehner R, Schmitz M, von Bonin M, Bornhäuser M, Ehninger G, Rieber EP, Bachmann M.

Leukemia. 2011 Jun;25(6):1053-6. doi: 10.1038/leu.2011.42. Epub 2011 Mar 18. No abstract available.


Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses.

Hänsel A, Günther C, Ingwersen J, Starke J, Schmitz M, Bachmann M, Meurer M, Rieber EP, Schäkel K.

J Allergy Clin Immunol. 2011 Mar;127(3):787-94.e1-9. doi: 10.1016/j.jaci.2010.12.009.


A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs).

Bippes CC, Feldmann A, Stamova S, Cartellieri M, Schwarzer A, Wehner R, Schmitz M, Rieber EP, Zhao S, Schäkel K, Temme A, Scofield RH, Kurien BT, Bartsch H, Bachmann M.

PLoS One. 2011 Jan 21;6(1):e16315. doi: 10.1371/journal.pone.0016315.


Dendritic cell-based immunotherapy for prostate cancer.

Jähnisch H, Füssel S, Kiessling A, Wehner R, Zastrow S, Bachmann M, Rieber EP, Wirth MP, Schmitz M.

Clin Dev Immunol. 2010;2010:517493. doi: 10.1155/2010/517493. Epub 2010 Nov 4. Review.


GD3-7-aldehyde is an apoptosis inducer and interacts with adenine nucleotide translocase.

Brenner C, Kniep B, Maillier E, Martel C, Franke C, Röber N, Bachmann M, Rieber EP, Sandhoff R.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):248-53. doi: 10.1016/j.bbrc.2009.11.044. Epub 2009 Nov 11.


Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells.

Wehner R, Wehrum D, Bornhäuser M, Zhao S, Schäkel K, Bachmann MP, Platzbecker U, Ehninger G, Rieber EP, Schmitz M.

Haematologica. 2009 Aug;94(8):1151-6. doi: 10.3324/haematol.2008.001735. Epub 2009 Jun 22.


Detection of autoantibodies to tumour-associated antigens in sera of patients with systemic autoimmunity using a novel protein microblot array.

Canzler U, Bartsch H, Ulitzsch S, Kurien BT, Dorri Y, Scofield RH, Grossmann K, Lehmann W, Pilarsky C, Denz A, Grützmann R, Conrad K, Schmitz M, Rieber EP, Distler W, Bachmann MP.

Scand J Immunol. 2009 Jun;69(6):563-9. doi: 10.1111/j.1365-3083.2009.02257.x.


Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.

Gerner M, Hölig K, Wehner R, Zhao S, Schäkel K, Bachmann MP, Rieber EP, Bornhäuser M, Schmitz M.

Transplantation. 2009 Apr 27;87(8):1134-9. doi: 10.1097/TP.0b013e31819e02d4.


Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.

Wehner R, Löbel B, Bornhäuser M, Schäkel K, Cartellieri M, Bachmann M, Rieber EP, Schmitz M.

Int J Cancer. 2009 Jan 15;124(2):358-66. doi: 10.1002/ijc.23962.


Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys.

Veazey RS, Acierno PM, McEvers KJ, Baumeister SH, Foster GJ, Rett MD, Newberg MH, Kuroda MJ, Williams K, Kim EY, Wolinsky SM, Rieber EP, Piatak M Jr, Lifson JD, Montefiori DC, Brown CR, Hirsch VM, Schmitz JE.

J Virol. 2008 Jun;82(11):5618-30. doi: 10.1128/JVI.02748-07. Epub 2008 Mar 26.


Contribution of CD8+ T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in Simian immunodeficiency virus-infected rhesus monkeys.

Kim EY, Veazey RS, Zahn R, McEvers KJ, Baumeister SH, Foster GJ, Rett MD, Newberg MH, Kuroda MJ, Rieber EP, Piatak M Jr, Lifson JD, Letvin NL, Wolinsky SM, Schmitz JE.

J Virol. 2008 Jun;82(11):5631-5. doi: 10.1128/JVI.02749-07. Epub 2008 Mar 26.


Advances in specific immunotherapy for prostate cancer.

Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M.

Eur Urol. 2008 Apr;53(4):694-708. Epub 2007 Nov 26. Review.


Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation.

Krause M, Schmitz M, Noessner E, Skrablin PS, Wehner R, Rieber EP, Baumann M.

Int J Radiat Biol. 2007 Nov-Dec;83(11-12):827-36.


G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity.

Baumeister SH, Hölig K, Bornhäuser M, Meurer M, Rieber EP, Schäkel K.

Blood. 2007 Oct 15;110(8):3078-81. Epub 2007 Jul 6. Erratum in: Blood. 2007 Dec 15;110(13):4197.


Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells.

Straube C, Wehner R, Wendisch M, Bornhäuser M, Bachmann M, Rieber EP, Schmitz M.

Leukemia. 2007 Jul;21(7):1464-71. Epub 2007 May 10.


Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.

Morgenroth A, Cartellieri M, Schmitz M, Günes S, Weigle B, Bachmann M, Abken H, Rieber EP, Temme A.

Prostate. 2007 Jul 1;67(10):1121-31.


Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.

Schmitz M, Temme A, Senner V, Ebner R, Schwind S, Stevanovic S, Wehner R, Schackert G, Schackert HK, Fussel M, Bachmann M, Rieber EP, Weigle B.

Br J Cancer. 2007 Apr 23;96(8):1293-301. Epub 2007 Mar 20. Erratum in: Br J Cancer. 2007 Jun 18;96(12):1928.


Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax.

Temme A, Rodriguez JA, Hendruschk S, Günes S, Weigle B, Schäkel K, Schmitz M, Bachmann M, Schackert G, Rieber EP.

Cancer Lett. 2007 Jun 8;250(2):177-93. Epub 2006 Nov 7.


Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation.

Bornhauser M, Thiede C, Babatz J, Schetelig J, Illmer T, Kiani A, Platzbecker U, Herr W, Rieber EP, Ehninger G, Schmitz M.

Leukemia. 2006 Nov;20(11):2055-7. Epub 2006 Aug 31. No abstract available.


Autoimmunity as a result of escape from RNA surveillance.

Bachmann MP, Bartsch H, Gross JK, Maier SM, Gross TF, Workman JL, James JA, Farris AD, Jung B, Franke C, Conrad K, Schmitz M, Büttner C, Buyon JP, Semsei I, Harley JB, Rieber EP.

J Immunol. 2006 Aug 1;177(3):1698-707.


Imatinib mesylate does not impair the immunogenicity of human myeloid blood dendritic cells.

Wehner R, Wendisch M, Schäkel K, Bornhäuser M, Platzbecker U, Mohr B, Temme A, Bachmann M, Rieber EP, Schmitz M.

Leukemia. 2006 Sep;20(9):1629-32. Epub 2006 Jul 13. No abstract available.


Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes.

Schäkel K, von Kietzell M, Hänsel A, Ebling A, Schulze L, Haase M, Semmler C, Sarfati M, Barclay AN, Randolph GJ, Meurer M, Rieber EP.

Immunity. 2006 Jun;24(6):767-77.


Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11.

Schmitz M, Wehner R, Stevanovic S, Kiessling A, Rieger MA, Temme A, Bachmann M, Rieber EP, Weigle B.

Cancer Lett. 2007 Jan 8;245(1-2):331-6. Epub 2006 Feb 28.


Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial.

Fuessel S, Meye A, Schmitz M, Zastrow S, Linné C, Richter K, Löbel B, Hakenberg OW, Hoelig K, Rieber EP, Wirth MP.

Prostate. 2006 Jun 1;66(8):811-21.


9-O-acetyl GD3 protects tumor cells from apoptosis.

Kniep B, Kniep E, Ozkucur N, Barz S, Bachmann M, Malisan F, Testi R, Rieber EP.

Int J Cancer. 2006 Jul 1;119(1):67-73.


Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells.

Demling N, Ehrhardt C, Kasper M, Laue M, Knels L, Rieber EP.

Cell Tissue Res. 2006 Mar;323(3):475-88. Epub 2005 Nov 29.


Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues.

Cunha AC, Weigle B, Kiessling A, Bachmann M, Rieber EP.

Cancer Lett. 2006 May 18;236(2):229-38. Epub 2005 Jul 19.


Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairs.

Fuessel S, Weigle B, Schmidt U, Baretton G, Koch R, Bachmann M, Rieber EP, Wirth MP, Meye A.

Cancer Lett. 2006 May 8;236(1):95-104. Epub 2005 Jun 27.


Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.

Schmitz JE, Johnson RP, McClure HM, Manson KH, Wyand MS, Kuroda MJ, Lifton MA, Khunkhun RS, McEvers KJ, Gillis J, Piatak M, Lifson JD, Grosschupff G, Racz P, Tenner-Racz K, Rieber EP, Kuus-Reichel K, Gelman RS, Letvin NL, Montefiori DC, Ruprecht RM, Desrosiers RC, Reimann KA.

J Virol. 2005 Jul;79(13):8131-41.


Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity.

Schmitz M, Zhao S, Deuse Y, Schäkel K, Wehner R, Wöhner H, Hölig K, Wienforth F, Kiessling A, Bornhäuser M, Temme A, Rieger MA, Weigle B, Bachmann M, Rieber EP.

J Immunol. 2005 Apr 1;174(7):4127-34.


D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.

Kiessling A, Weigle B, Fuessel S, Ebner R, Meye A, Rieger MA, Schmitz M, Temme A, Bachmann M, Wirth MP, Rieber EP.

Prostate. 2005 Sep 1;64(4):387-400.


Inhibition of malignant glioma cell growth by a survivin mutant retrovirus.

Temme A, Herzig E, Weigle B, Morgenroth A, Schmitz M, Kiessling A, Rieger MA, Schackert HK, Rieber EP.

Hum Gene Ther. 2005 Feb;16(2):209-22.


Increased p21(ras) activity in human fibroblasts transduced with survivin enhances cell proliferation.

Temme A, Diestelkoetter-Bachert P, Schmitz M, Morgenroth A, Weigle B, Rieger MA, Kiessling A, Rieber EP.

Biochem Biophys Res Commun. 2005 Feb 18;327(3):765-73.


Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinoma.

Wolkersdörfer GW, Marx C, Brown J, Schröder S, Füssel M, Rieber EP, Kuhlisch E, Ehninger G, Bornstein SR.

J Clin Endocrinol Metab. 2005 Mar;90(3):1768-74. Epub 2004 Dec 7.


Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas.

Weigle B, Ebner R, Temme A, Schwind S, Schmitz M, Kiessling A, Rieger MA, Schackert G, Schackert HK, Rieber EP.

Oncol Rep. 2005 Jan;13(1):139-44.


D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate.

Weigle B, Fuessel S, Ebner R, Temme A, Schmitz M, Schwind S, Kiessling A, Rieger MA, Meye A, Bachmann M, Wirth MP, Rieber EP.

Biochem Biophys Res Commun. 2004 Sep 10;322(1):239-49.


Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.

Rieger MA, Ebner R, Bell DR, Kiessling A, Rohayem J, Schmitz M, Temme A, Rieber EP, Weigle B.

Cancer Res. 2004 Apr 1;64(7):2357-64.


D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.

Weigle B, Kiessling A, Ebner R, Fuessel S, Temme A, Meye A, Schmitz M, Rieger MA, Ockert D, Wirth MP, Rieber EP.

Int J Cancer. 2004 May 10;109(6):882-92.


Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein.

Kiessling A, Stevanovic S, Füssel S, Weigle B, Rieger MA, Temme A, Rieber EP, Schmitz M.

Br J Cancer. 2004 Mar 8;90(5):1034-40.


Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8.

Kiessling A, Füssel S, Schmitz M, Stevanovic S, Meye A, Weigle B, Klenk U, Wirth MP, Rieber EP.

Prostate. 2003 Sep 1;56(4):270-9.


Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell.

Temme A, Rieger M, Reber F, Lindemann D, Weigle B, Diestelkoetter-Bachert P, Ehninger G, Tatsuka M, Terada Y, Rieber EP.

Mol Biol Cell. 2003 Jan;14(1):78-92.


Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34(+) cord blood-derived dendritic cells.

Temme A, Morgenroth A, Schmitz M, Weigle B, Rohayem J, Lindemann D, Füssel M, Ehninger G, Rieber EP.

Gene Ther. 2002 Nov;9(22):1551-60.


Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients.

Kiessling A, Schmitz M, Stevanovic S, Weigle B, Hölig K, Füssel M, Füssel S, Meye A, Wirth MP, Rieber EP.

Int J Cancer. 2002 Dec 1;102(4):390-7.


Cancer immunotherapy: novel strategies and clinical experiences.

Schmitz M, Bornhäuser M, Ockert D, Rieber EP.

Trends Immunol. 2002 Sep;23(9):428-9. No abstract available.


Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity.

Schmitz M, Zhao S, Schäkel K, Bornhäuser M, Ockert D, Rieber EP.

Blood. 2002 Aug 15;100(4):1502-4.


An in vitro vitellogenin bioassay for oestrogenic substances in the medaka (Oryzias latipes).

Kordes C, Rieber EP, Gutzeit HO.

Aquat Toxicol. 2002 Aug;58(3-4):151-64.


Supplemental Content

Loading ...
Support Center